Brean Capital reiterated a Buy on Repros Therapeutics (NASDAQ: RPRX) and raised its price target to price target of $41.00 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE